Advanced thinking
Tackling the development, scale up and scale out of ATMP to effectively address rare and complex diseases..
FACILITATED BY
JACQUELINE BARRY | Chief Clinical Officer | Cell and Gene Therapy Catapult
PANELLISTS INCLUDE
CHRIS BALDWIN | Supply Chain Director for Cell & Gene Therapy Products | GSK
CHRIS VANN | Chief Operating Officer | Autolus
KWOK PANG | Chief Operating Officer | Autolomous
BRIAN MULLAN | Head of Innovation, Analytical and Process Development | Yposkesi